Compile Data Set for Download or QSAR
maximum 50k data
Found 412 with Last Name = 'anis' and Initial = 'i'
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22925((8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxol...)
Affinity DataKi:  0.0330nM ΔG°:  -59.2kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMedDrugBank

TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22947(1-[(2R)-4-{5-[3-(4-chlorophenyl)propoxy]-1-methyl-...)
Affinity DataKi:  4.90nM ΔG°:  -47.0kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22937(1-[(2R)-4-{6-[(benzylcarbamoyl)amino]-1H-indol-1-y...)
Affinity DataKi:  7.5nM ΔG°:  -45.9kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22920(1-[(2R)-1-hydroxy-4-{6-[3-(1-methyl-1H-1,3-benzodi...)
Affinity DataKi:  7.70nM ΔG°:  -45.8kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22920(1-[(2R)-1-hydroxy-4-{6-[3-(1-methyl-1H-1,3-benzodi...)
Affinity DataKi:  7.70nM ΔG°:  -45.8kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22920(1-[(2R)-1-hydroxy-4-{6-[3-(1-methyl-1H-1,3-benzodi...)
Affinity DataKi:  7.70nM ΔG°:  -45.8kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22950(1-[(3R,4S)-4-hydroxy-1-(naphthalen-2-yloxy)pentan-...)
Affinity DataKi:  9.80nM ΔG°:  -45.3kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22948(1-[(1R,2S)-2-hydroxy-1-(2-naphthalen-1-ylethyl)pro...)
Affinity DataKi:  11nM ΔG°:  -45.0kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22931(1-[(2R)-1-hydroxy-4-[6-(5-phenylpentanamido)-1H-in...)
Affinity DataKi:  11nM ΔG°:  -45.0kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22939(1-[(2R)-1-hydroxy-4-[6-(4-phenylbutoxy)-1H-indol-1...)
Affinity DataKi:  12nM ΔG°:  -44.8kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22942(1-[(2R)-4-{6-[3-(4-chlorophenyl)propoxy]-1H-indol-...)
Affinity DataKi:  13nM ΔG°:  -44.6kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22946(1-[(2R)-4-[5-(hexyloxy)-1-methyl-1H-indol-3-yl]-1-...)
Affinity DataKi:  13nM ΔG°:  -44.6kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22949(1-[(3R,4S)-1-(2,3-dichlorophenyl)-4-hydroxypentan-...)
Affinity DataKi:  13nM ΔG°:  -44.6kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22930(1-[(2R)-1-hydroxy-4-[6-(4-phenylbutanamido)-1H-ind...)
Affinity DataKi:  16nM ΔG°:  -44.0kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22938(1-[(2R)-1-hydroxy-4-[6-(3-phenylpropoxy)-1H-indol-...)
Affinity DataKi:  17nM ΔG°:  -43.9kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22936(1-[(2R)-1-hydroxy-4-{6-[3-(pyridin-3-yl)propanamid...)
Affinity DataKi:  17nM ΔG°:  -43.9kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22928(1-[(2R)-4-(6-hexanamido-1H-indol-1-yl)-1-hydroxybu...)
Affinity DataKi:  24nM ΔG°:  -43.1kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22945(1-[(2R)-1-hydroxy-4-[1-methyl-5-(3-phenylpropoxy)-...)
Affinity DataKi:  26nM ΔG°:  -42.9kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22929(1-[(2R)-1-hydroxy-4-[6-(3-phenylpropanamido)-1H-in...)
Affinity DataKi:  30nM ΔG°:  -42.5kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22935(1-[(2R)-1-hydroxy-4-{6-[4-(4-methylphenyl)butanami...)
Affinity DataKi:  34nM ΔG°:  -42.2kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22926(3-(6-amino-9H-purin-9-yl)nonan-2-ol | EHNA | Eryth...)
Affinity DataKi:  37nM ΔG°:  -42.0kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22933(1-[(2R)-1-hydroxy-4-{6-[3-(4-methylphenyl)propanam...)
Affinity DataKi:  38nM ΔG°:  -41.9kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSphingosine kinase 1(Homo sapiens (Human))
Kyoto University

Curated by ChEMBL
LigandPNGBDBM50175277(CHEMBL3809675)
Affinity DataKi:  40nMAssay Description:Inhibition of recombinant human SphK1 expressed in baculovirus infected sf9 cells using D-erythro-sphingosine as substrate in presence of [gamma-33P]...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22940(1-[(2R)-4-[6-(hexyloxy)-1H-indol-1-yl]-1-hydroxybu...)
Affinity DataKi:  55nM ΔG°:  -41.0kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22934(1-[(2R)-1-hydroxy-4-{6-[3-(4-methoxyphenyl)propana...)
Affinity DataKi:  57nM ΔG°:  -40.9kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22932(1-[(2R)-1-hydroxy-4-[6-(6-phenylhexanamido)-1H-ind...)
Affinity DataKi:  91nM ΔG°:  -39.8kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMaltase-glucoamylase(Homo sapiens (Human))
Kindai University

Curated by ChEMBL
LigandPNGBDBM50330955((1S,2S)-3-[(2R,3S,4S)-3,4-dihydroxy-2-(hydroxymeth...)
Affinity DataKi:  190nMAssay Description:Inhibition of recombinant human maltase-glucoamylase using p-nitrophenyl-alpha-D-glucopyranoside as substrate incubated for 35 mins by microtiter pla...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22941(1-[(2R)-4-(6-butoxy-1H-indol-1-yl)-1-hydroxybutan-...)
Affinity DataKi:  240nM ΔG°:  -37.4kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22919(1-[1-hydroxy-4-(naphthalen-1-yl)butan-2-yl]-1H-imi...)
Affinity DataKi:  680nM ΔG°:  -34.8kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22918(2-(4-{5-[(1H-1,3-benzodiazol-2-ylamino)methyl]thio...)
Affinity DataKi:  1.20E+3nM ΔG°:  -33.5kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetSphingosine kinase 2(Homo sapiens (Human))
Kyoto University

Curated by ChEMBL
LigandPNGBDBM174110((S)-2-(3-(4-octylphenyl)-1,2,4- oxadiazol-5-yl)aze...)
Affinity DataKi:  1.20E+3nMAssay Description:Inhibition of recombinant human SphK2 expressed in baculovirus infected sf9 cells using D-erythro-sphingosine as substrate after 20 mins in presence ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22927(1-[(2R)-4-(6-acetamido-1H-indol-1-yl)-1-hydroxybut...)
Affinity DataKi:  1.30E+3nM ΔG°:  -33.3kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22943(1-[(2R)-1-hydroxy-4-[5-(3-phenylpropoxy)-1H-indol-...)
Affinity DataKi:  1.90E+3nM ΔG°:  -32.3kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22917(1-(1-hydroxy-4-phenylbutan-2-yl)-1H-imidazole-4-ca...)
Affinity DataKi:  5.90E+3nM ΔG°:  -29.5kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22917(1-(1-hydroxy-4-phenylbutan-2-yl)-1H-imidazole-4-ca...)
Affinity DataKi:  5.90E+3nM ΔG°:  -29.5kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
TargetMaltase-glucoamylase(Homo sapiens (Human))
Kindai University

Curated by ChEMBL
LigandPNGBDBM50549692(CHEMBL4749306)
Affinity DataKi:  6.00E+3nMAssay Description:Inhibition of recombinant human maltase-glucoamylase using p-nitrophenyl-alpha-D-glucopyranoside as substrate incubated for 35 mins by microtiter pla...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22944(1-[(2R)-4-[5-(hexyloxy)-1H-indol-1-yl]-1-hydroxybu...)
Affinity DataKi:  6.20E+3nM ΔG°:  -29.4kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSphingosine kinase 1(Homo sapiens (Human))
Kyoto University

Curated by ChEMBL
LigandPNGBDBM174110((S)-2-(3-(4-octylphenyl)-1,2,4- oxadiazol-5-yl)aze...)
Affinity DataKi: >1.00E+4nMAssay Description:Inhibition of recombinant human SphK1 expressed in baculovirus infected sf9 cells using D-erythro-sphingosine as substrate after 20 mins in presence ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSphingosine kinase 2(Mus musculus (Mouse))
Kyoto University

Curated by ChEMBL
LigandPNGBDBM50175277(CHEMBL3809675)
Affinity DataKi:  1.41E+4nMAssay Description:Inhibition of recombinant mouse SphK2 expressed in baculovirus infected sf9 cells using D-erythro-sphingosine as substrate in presence of [gamma-33P]...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMaltase-glucoamylase(Homo sapiens (Human))
Kindai University

Curated by ChEMBL
LigandPNGBDBM50549691(CHEMBL4754034)
Affinity DataKi:  3.20E+4nMAssay Description:Inhibition of recombinant human maltase-glucoamylase using p-nitrophenyl-alpha-D-glucopyranoside as substrate incubated for 35 mins by microtiter pla...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetMaltase-glucoamylase(Homo sapiens (Human))
Kindai University

Curated by ChEMBL
LigandPNGBDBM50549693(CHEMBL4750690)
Affinity DataKi:  5.10E+4nMAssay Description:Inhibition of recombinant human maltase-glucoamylase using p-nitrophenyl-alpha-D-glucopyranoside as substrate incubated for 35 mins by microtiter pla...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22921(1-(2-hydroxy-1-phenylethyl)-1H-imidazole-4-carboxa...)
Affinity DataKi:  5.40E+4nM ΔG°:  -24.1kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22922(1-(2-hydroxy-1-phenylethyl)-1H-imidazole-4-carboxy...)
Affinity DataKi: >1.00E+5nM ΔG°: >-22.6kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22923(imidazole-4-carboxylate compound, 5 | methyl 1-(2-...)
Affinity DataKi: >1.00E+5nM ΔG°: >-22.6kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine deaminase(Homo sapiens (Human))
Fujisawa Pharmaceutical

LigandPNGBDBM22924(2-[4-(hydroxymethyl)-1H-imidazol-1-yl]-2-phenyleth...)
Affinity DataKi: >1.00E+5nM ΔG°: >-22.6kJ/molepH: 7.4 T: 2°CAssay Description:The reaction velocity was measured by change in absorbance at 265nm (A265) resulting from the deamination of adenosine. The reaction was started by a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50070467(1-[1-[2-(3-Aza-bicyclo[3.2.2]non-3-yl)-2-oxo-ethyl...)
Affinity DataIC50:  0.0870nMAssay Description:Compound was evaluated for the inhibition of 124 I-CCK-8 binding at Cholecystokinin type B receptor on guinea pig cerebral cortical membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50070464(1-[1-[2-(3-Aza-bicyclo[3.2.2]non-3-yl)-2-oxo-ethyl...)
Affinity DataIC50:  0.660nMAssay Description:Compound was evaluated for the inhibition of 124 I-CCK-8 binding at CCK-B receptorCholecystokinin type B receptorcerebral cortical membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50070466(1-[1-[2-(3-Aza-bicyclo[3.2.2]non-3-yl)-2-oxo-ethyl...)
Affinity DataIC50:  0.680nMAssay Description:Compound was evaluated for the inhibition of 124 I-CCK-8 binding at Cholecystokinin type B receptor on guinea pig cerebral cortical membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50070465(1-[1-[2-(3-Aza-bicyclo[3.2.2]non-3-yl)-2-oxo-ethyl...)
Affinity DataIC50:  0.810nMAssay Description:Compound was evaluated for the inhibition of 124 I-CCK-8 binding at Cholecystokinin type B receptor on guinea pig cerebral cortical membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSphingosine kinase 1(Homo sapiens (Human))
Kyoto University

Curated by ChEMBL
LigandPNGBDBM50041978(CHEMBL3134157)
Affinity DataIC50:  2.70nMAssay Description:Inhibition of recombinant C-terminal His6-tagged human SphK1 expressed in baculovirus infected sf21 cells using FITC-sphingosine as substrate after 1...More data for this Ligand-Target Pair
Displayed 1 to 50 (of 412 total ) | Next | Last >>
Jump to: